Correlation Between Blueprint Medicines and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Sangamo Therapeutics, you can compare the effects of market volatilities on Blueprint Medicines and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Sangamo Therapeutics.
Diversification Opportunities for Blueprint Medicines and Sangamo Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Blueprint and Sangamo is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Sangamo Therapeutics
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.31 times more return on investment than Sangamo Therapeutics. However, Blueprint Medicines Corp is 3.27 times less risky than Sangamo Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Sangamo Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 9,762 in Blueprint Medicines Corp on November 1, 2024 and sell it today you would earn a total of 1,643 from holding Blueprint Medicines Corp or generate 16.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Sangamo Therapeutics
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Sangamo Therapeutics |
Blueprint Medicines and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Sangamo Therapeutics
The main advantage of trading using opposite Blueprint Medicines and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |